Moderna and Tesla rose in premarket, while Novavax and Nikola fell

Moderna and Tesla rose in premarket, while Novavax and Nikola fell

Investing.com - Moderna (NASDAQ: MRNA) shares soared 9% in New York Stock Exchange premarket Monday after the biotech company said it would apply for an emergency permit to use its COVID-19 vaccine in the US and Europe. based on the complete results of the latest study showing that her drug is 94.1% effective as well as 100% effective in severe cases and has no major safety concerns.

Pfizer (NYSE: PFE) shares surged 1.8% after the Financial Times said the UK intends to approve the pharmaceutical giant's COVID-19 vaccine within days and could begin distribution as early as December 7.

Novavax (NASDAQ: NVAX) shares tumbled 9.2% after the pharmaceutical company postponed the start of the latest US trials of an experimental COVID-19 vaccine. Trials are now expected to begin in the coming weeks, whereas November was previously considered.

Tesla (NASDAQ: TSLA) Shares Up 3% After Electric Vehicle Maker Received The Green Light To Sell Its Model Y SUV In China.

S Shares&P Global (NYSE: SPGI) fell 2.5% after the data giant agreed to buy IHS Markit (NYSE: INFO) for roughly $ 39 billion plus $ 4.8 billion in debt, creating a major player in an increasingly competitive financial information market.

HSBC (NYSE: HSBC) shares dropped 2% after the Financial Times reported that the banking giant was considering a complete exit from the US retail banking system - an area in which it has always struggled.

Apple (NASDAQ: AAPL) shares gained 0.4%, despite the Italian antitrust authority fining the tech giant € 10m ($ 12m) for "aggressive and misleading" commercial practices against its iPhone.

Nikola (NASDAQ: NKLA) shares lost 3.1% amid fears that company founder Trevor Milton will sell all or part of his 91.6 million shares - about a quarter of all issued shares - and may do so today. Coincidentally or not, Nikola's stock jumped briefly after the company issued a press release stating that General Motors (NYSE: GM) will no longer buy a stake in the company and will not participate in the development of Badger pickups. Nikola will return all collateral received for Badger.

- Written by Peter Nurse